1. ‘Digistain’
Mid Infrared Chemical Imaging For
Cancer Diagnosis,
Trialling A New Technology
Supervisor: Prof. Chris Phillips
By
A Nisa M A
2. Special Gratitude
Digistain Team, Imperial College London
Prof. Chris Phillips
Dr. Hemmel Amrania
Laurence Drummond
Katy Morgan
Andres Olivares
Pathologist, Charing Cross Hospital & ICL
Prof. Sami Shousha
4. The Issues
1. Folded samples
2. Sample delay
3. Bad images
4. Zero & Negative PA ratio
5. Invasive samples difficulties
5. Trial Achievement
1. Data reproducibility
2. Two data analysis methods
3. Strong correlation of Digistain Index vs
Histopathology Cancer Grading
4. Additional system improvement
6. Significance of Digistain
1. Objective diagnosis
2. Quantitative cancer malignancy marker
3. Cost effective instrument
4. Fast and easy to use
5. Contribute correct and effective treatment
6. Contribute reduce cancer morbidity &
mortality rate
7. Carcinoma of the Breast
Serious condition of breast disorder
Mostly adenocarcinomas (glandular/secretory cells
origin)
Originate in the epithelium (mammary ducts or
lobular glands)
Vast majority are ductal origin
2 types: Intraduct (DCIS) or Infiltrating (Invasive)
Peak incident a decade before menopause
Non-invasive (DCIS) & Invasive
8. Digistain Principle
1. Imaging at 4 wavelengths: Ap, Ab, Pp, Pb
2. P/A ratio N/C ratio Tumour malignancy
marker
3. Digistain Index: sum of mean PA ratio/no.
of sample, in a cancer grade class
18. The Improvement
1. Current program: thresholding blocks at
peak images
2. New labview program: bad image
elimination
3. Analysis: 3rd method, eliminates tissue
intermixing at peak images
23. 1. Quantitative and refined cancer malignancy
marker
2. Objective histopathology diagnosis technique
3. Cost effective instrument
4. Fast and easy to use
5. Contribute mainly for the correct and effective
treatment
6. Contribute to reduce cancer morbidity &
mortality rate
Significance of Digistain